Skip to main content

The Lipid A Receptor

  • Chapter

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 667))

Abstract

The lipid A receptor consists of several subunits. Lipopolysaccharide binding protein (LBP) is a serum protein facilitating association of lipid A with CD14. The Lipid A-LBP-CD14 complex is further delivered to Toll-like receptor 4 (TLR4), which is essential for lipid A-mediated cellular activation. TLR4 associates with MD-2, which is required for surface expression and recognition of lipid A. In addition, the RP 10S-MD-1 complex mediates TLR4-mediated response in B cells and negatively regulates TLR4-mediated response in dendritic cells. Thus, lipid A receptor’s function varies among cell populations.

Keywords

These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
EUR   29.95
Price includes VAT (France)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
EUR   117.69
Price includes VAT (France)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
EUR   158.24
Price includes VAT (France)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
EUR   158.24
Price includes VAT (France)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Raetz CR, Whitfield C. Lipopolysaccharide endotoxins. Annu Rev Biochem 2002; 71:635–700.

    Article  CAS  PubMed  Google Scholar 

  2. Tobias PS, Soldau K, Ulevitch R J. Isolation of a lipopolysaccharide-binding acute phase reactant from rabbit serum. J Exp Med 1986; 164(3):777–793.

    Article  CAS  PubMed  Google Scholar 

  3. Schumann RR, Leong SR, Flaggs GW et al. Structure and function of lipopolysaccharide binding protein. Science 1990; 249(4975):1429–1431.

    Article  CAS  PubMed  Google Scholar 

  4. Wurfel MM, Monks BG, Ingalls RR et al. Targeted deletion of the lipopolysaccharide (LPS)-binding protein gene leads to profound suppression of LPS responses ex vivo, whereas in vivo responses remain intact. J Exp Med 1997; 186(12):2051–2056.

    Article  CAS  PubMed  Google Scholar 

  5. Wright SD, Ramos RA, Tobias PS et al. CD 14, a receptor for complexes of lipopolysaccharide (LPS) and iPS binding protein. Science 1990; 249(4975):1431–1433.

    Article  CAS  PubMed  Google Scholar 

  6. Tobias PS, Soldau K, Gegner JA er al. Lipopolysaccharide binding protein-mediated complexation of lipopolysaccharide with soluble CD14. J Biol Chem 1995; 270(18):10482–10488.

    Article  CAS  PubMed  Google Scholar 

  7. Moore KJ andersson IP, Ingalls RR et al. Divergent response to LPS and bacteria in CD14-deficient murine macrophages. J Immunol 2000; 165(8):4272–4280.

    CAS  PubMed  Google Scholar 

  8. Lemaitre B, Nicolas E, Michaut L er al. The dorsoventral regulatory gene cassette sparzle/Toll/cactus controls the potent antifungal response in Drosophila adults. Cell 1996; 86(6):973–983.

    Article  CAS  PubMed  Google Scholar 

  9. Medzhitov R, Preston-Hurlburt P, Janeway CA, Jr. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 1997; 388(6640):394–397.

    Article  CAS  PubMed  Google Scholar 

  10. Takeda K, Kaisho T, Akira S. Toll-like receptors. Annu Rev Immunol 2003; 21:335–376.

    Article  CAS  PubMed  Google Scholar 

  11. Akira S, Takeda K. Toll-like receptor signalling. Nat Rev Immunol 2004; 4(7):499–511.

    Article  CAS  PubMed  Google Scholar 

  12. Poltorak A, He X, Smirnova I et al. Defective LPS signaling in C3H/He J and C57BL/I0ScCr mice: mutations in Tlr4 gene. Science 1998; 282(5396):2085–2088.

    Article  CAS  PubMed  Google Scholar 

  13. Hoshino K, Takeuchi O, Kawai T et al. Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J Immunol 1999; 162(7):3749–3752.

    CAS  PubMed  Google Scholar 

  14. Netea MG, van Deuren M, Kullberg BJ et al. Does the shape of lipid A determine the interaction of LPS with Toll-like receptors? Trends Immunol 2002; 23(3):135–139.

    Article  CAS  PubMed  Google Scholar 

  15. Werts C, Tapping RI, Mathison JC et al. Leptospiral lipopolysaccharide activates cells through a TLR2-dependent mechanism. Nat Immunol 2001; 2(4):346–352.

    Article  CAS  PubMed  Google Scholar 

  16. Nahori MA, Fournie-Amazouz E, Que-Gewirth NS et al. Differential TLR recognition of leptospiral lipid A and lipopolysaccharide in murine and human cells. J Immunol 2005; 175(9):6022–6031.

    CAS  PubMed  Google Scholar 

  17. Byrd-Leiter CA, Block EF, Takeda K et al. The role of MyD88 and TLR4 in the LPS-mimetic activity of Taxol. Eur J Immunol 2001; 31(8):2448–2457.

    Article  Google Scholar 

  18. Kurt-Jones EA, Popova L, Kwinn L et al. Pattern recognition receptors TLR4 and CD 14 mediate response to respiratory syncytial virus. Nat Immunol 2000; 1(5):398–401.

    Article  CAS  PubMed  Google Scholar 

  19. Rassa JC, Meyers JL, Zhang Y et al. Murine retroviruses activate B cells via interaction with toll-like receptor 4. Proc Natl Acad Sci USA 2002;99(4):2281–2286.

    Article  CAS  PubMed  Google Scholar 

  20. Takeda K, Akira S. Toll-like receptors in innate immunity. Int Immunol 2005; 17(1):1–14.

    Article  CAS  PubMed  Google Scholar 

  21. Gao B, Tsan ME Endotoxin contamination in recombinant human heat shock protein 70 (Hsp70) preparation is responsible for the induction of tumor necrosis factor alpha releaseby murine macrophages. J Biol Chem 2003; 278(1):174–179.

    Article  CAS  PubMed  Google Scholar 

  22. Shimazu R, Akashi S, Ogata H et al. MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4. J Exp Med 1999; 189(11):1777–1782.

    Article  CAS  PubMed  Google Scholar 

  23. Akashi S, Shimazu R, Ogata H et al. Cutting edge: cell surface expression and lipopolysaccharide signaling via the toll-like receptor 4-MD-2 complex on mouse peritoneal macrophages. J Immunol 2000; 164(7):3471–3475.

    CAS  PubMed  Google Scholar 

  24. Schromm AB, Lien E, Henneke P et al. Molecular genetic analysis of an endotoxin nonresponder mutant cell line: a point mutation in a conserved region of MD-2 abolishes endotoxin-induced signaling. J Exp Med 2001; 194(1):79–88.

    Article  CAS  PubMed  Google Scholar 

  25. Nagai Y, Akashi S, Nagafuku M et al. Essential role of MD-2 in LPS responsiveness and TLR4 distribution. Nat Immunol 2002; 3(7):667–672.

    CAS  PubMed  Google Scholar 

  26. Visintin A, Mazzoni A, Spitzer JA et al. Secreted MD-2 is a large polymeric protein that efficiently confers lipopolysaccharide sensitivity to Toll-like receptor 4. Proc Natl Acad Sci USA 2001; 98(21):12156–12161.

    Article  CAS  PubMed  Google Scholar 

  27. Randow F, Seed B. Endoplasmic reticulum chaperone gp96 is required for innate immunity but not cell viability. Nat Cell Biol 2001; 3(10):891–896.

    Article  CAS  PubMed  Google Scholar 

  28. Jiang Q, Akashi S, Miyake K et al. Lipopolysaccharide induces physical proximity between CD 14 and toll-like receptor 4 (TLR4) prior to nuclear translocation of NF-kappa B. J Immunol 2000; 165(7):3541–3544.

    CAS  PubMed  Google Scholar 

  29. da Silva Correia J, Soldau K, Christen U et al. Lipopolysaccharide is in close proximity to each of the proteins in its membrane receptor complex transfer from CD14 to TLR4 and MD-2. J Biol Chem 2001; 276(24):21129–21135.

    Article  PubMed  Google Scholar 

  30. da Silva Correia J, Ulevitch RJ. MD-2 and TLR4 N-linked glycosylations are important for a functional lipopolysaccharide receptor. J Biol Chem 2002; 277(3):1845–1854.

    Article  PubMed  Google Scholar 

  31. Akashi S, Nagai Y, Ogata H et al. Human MD-2 confers on mouse Toll-like receptor 4 species-specific lipopolysaccharide recognition. Int Immunol 2001; 13(12):1595–1599.

    Article  CAS  PubMed  Google Scholar 

  32. Akashi S, Saitoh S, Wakabayashi Y et al. Lipopolysaccharide interaction with cell surface Toll-like receptor 4-MD-2: higher affinity than that with MD-2 or CD14. J Exp Med 2003; 198(7):1035–1042.

    Article  CAS  PubMed  Google Scholar 

  33. Miyake K, Yamashita Y, Ogata M et al. RP105, a novel B cell surface molecule implicated in B cell activation, is a member of the leucine-rich repeat protein family. J Immunol 1995; 154(7):3333–3340.

    CAS  PubMed  Google Scholar 

  34. Ogata H, Su I, Miyake K et ale The toll-like receptor protein RP105 regulates lipopolysaccharide signaling in B cells. J Exp Med 2000; 192(1):23–29.

    Article  CAS  PubMed  Google Scholar 

  35. Miyake K, Shimazu R, Kondo J et al. Mouse MD-1, a molecule that is physically associated with RP105 and positively regulates its expression. J Immunol 1998; 161(3):1348–1353.

    CAS  PubMed  Google Scholar 

  36. Nagai Y, Shimazu R, Ogata H et al. Requirement for MD-1 in cell surface expression of RP105/CD180 and B-cell responsiveness to lipopolysaccharide. Blood 2002; 99(5): 1699–1705.

    Article  CAS  PubMed  Google Scholar 

  37. Divanovic S, Trompette A, Atabani SF et al. Negative regulation of Toll-like receptor 4 signaling by the Toll-like receptor homolog RP105. Nat Immunol 2005; 6(6):571–578.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kiyoshi Takeda .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Landes Bioscience and Springer Science+Business Media

About this chapter

Cite this chapter

Takeda, K. (2009). The Lipid A Receptor. In: Jeannin, JF. (eds) Lipid A in Cancer Therapy. Advances in Experimental Medicine and Biology, vol 667. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-1603-7_5

Download citation

Publish with us

Policies and ethics